- call +1-201-465-4211
- email sales@mrinsights.biz
Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy.
Scope of the Report:
This report focuses on the Chemotherapy-induced Nausea and Vomiting Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest sales region of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
The worldwide market for Chemotherapy-induced Nausea and Vomiting Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Helsinn
Heron Therapeutics
Merck & Co
Tesaro
Acacia Pharma
Aphios
Barr Laboratories
Baxter Healthcare
Eisai
Especificos Stendhal
F.Hoffmann La Roche
Mundipharma
Mylan Pharmaceuticals
OPKO Health
Orchid Healthcare
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Aloxi (palonosetron)
Kytril Generic (granisetron)
Emend (aprepitant)
Akynzeo (netupitant-palonosetron)
Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Tract Cancer
Others
There are 15 Chapters to deeply display the global Chemotherapy-induced Nausea and Vomiting Drugs market.
Chapter 1, to describe Chemotherapy-induced Nausea and Vomiting Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Chemotherapy-induced Nausea and Vomiting Drugs, with sales, revenue, and price of Chemotherapy-induced Nausea and Vomiting Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Chemotherapy-induced Nausea and Vomiting Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Chemotherapy-induced Nausea and Vomiting Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Chemotherapy-induced Nausea and Vomiting Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Chemotherapy-induced Nausea and Vomiting Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Aloxi (palonosetron)
1.2.2 Kytril Generic (granisetron)
1.2.3 Emend (aprepitant)
1.2.4 Akynzeo (netupitant-palonosetron)
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Tract Cancer
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Helsinn
2.2.1 Business Overview
2.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Heron Therapeutics
2.3.1 Business Overview
2.3.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck & Co
2.4.1 Business Overview
2.4.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Tesaro
2.5.1 Business Overview
2.5.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Acacia Pharma
2.6.1 Business Overview
2.6.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Aphios
2.7.1 Business Overview
2.7.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aphios Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Barr Laboratories
2.8.1 Business Overview
2.8.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Baxter Healthcare
2.9.1 Business Overview
2.9.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Eisai
2.10.1 Business Overview
2.10.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Especificos Stendhal
2.11.1 Business Overview
2.11.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Especificos Stendhal Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 F.Hoffmann La Roche
2.12.1 Business Overview
2.12.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 F.Hoffmann La Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Mundipharma
2.13.1 Business Overview
2.13.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Mylan Pharmaceuticals
2.14.1 Business Overview
2.14.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Mylan Pharmaceuticals Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 OPKO Health
2.15.1 Business Overview
2.15.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 OPKO Health Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Orchid Healthcare
2.16.1 Business Overview
2.16.2 Chemotherapy-induced Nausea and Vomiting Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Orchid Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis by Regions
4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
4.5 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
5 North America Chemotherapy-induced Nausea and Vomiting Drugs by Countries
5.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
6 Europe Chemotherapy-induced Nausea and Vomiting Drugs by Countries
6.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
6.3 UK Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
6.4 France Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs by Countries
7.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
7.5 India Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
8 South America Chemotherapy-induced Nausea and Vomiting Drugs by Countries
8.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs by Countries
9.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
10 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Segment by Type
10.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Type (2013-2018)
10.2 Aloxi (palonosetron) Sales Growth and Price
10.2.1 Global Aloxi (palonosetron) Sales Growth (2013-2018)
10.2.2 Global Aloxi (palonosetron) Price (2013-2018)
10.3 Kytril Generic (granisetron) Sales Growth and Price
10.3.1 Global Kytril Generic (granisetron) Sales Growth (2013-2018)
10.3.2 Global Kytril Generic (granisetron) Price (2013-2018)
10.4 Emend (aprepitant) Sales Growth and Price
10.4.1 Global Emend (aprepitant) Sales Growth (2013-2018)
10.4.2 Global Emend (aprepitant) Price (2013-2018)
10.5 Akynzeo (netupitant-palonosetron) Sales Growth and Price
10.5.1 Global Akynzeo (netupitant-palonosetron) Sales Growth (2013-2018)
10.5.2 Global Akynzeo (netupitant-palonosetron) Price (2013-2018)
11 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Segment by Application
11.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2013-2018)
11.2 Blood Cancer Sales Growth (2013-2018)
11.3 Breast Cancer Sales Growth (2013-2018)
11.4 Gastrointestinal Tract Cancer Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.2.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.2.4 South America Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.3 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Type (2018-2023)
12.4 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Chemotherapy-induced Nausea and Vomiting Drugs Picture
Table Product Specifications of Chemotherapy-induced Nausea and Vomiting Drugs
Figure Global Sales Market Shar
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
